W
Wonbiogen Co Ltd
KOSDAQ:307280
Wonbiogen Co Ltd
KOSDAQ:307280
Price:
2 165
KRW
1.41%
Market Closed
Market Cap:
₩49.2B
Income Statement
Earnings Waterfall
Wonbiogen Co Ltd
Wonbiogen Co Ltd
Income Statement
Wonbiogen Co Ltd
Wonbiogen Co Ltd
Currency: KRW
| Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||
| Interest Expense |
29
|
29
|
29
|
30
|
30
|
30
|
102
|
160
|
177
|
431
|
836
|
1 013
|
1 380
|
1 274
|
803
|
581
|
252
|
117
|
118
|
113
|
64
|
58
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2 868
N/A
|
7 601
+165%
|
12 277
+62%
|
17 721
+44%
|
21 868
+23%
|
31 391
+44%
|
33 558
+7%
|
26 748
-20%
|
34 541
+29%
|
27 782
-20%
|
27 891
+0%
|
29 615
+6%
|
28 892
-2%
|
36 462
+26%
|
36 374
0%
|
30 440
-16%
|
38 695
+27%
|
32 025
-17%
|
34 381
+7%
|
|
| Gross Profit | ||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(1 768)
|
(4 596)
|
(7 348)
|
(10 126)
|
(12 375)
|
(17 395)
|
(17 993)
|
(14 283)
|
(18 654)
|
(14 400)
|
(14 735)
|
(15 420)
|
(15 069)
|
(19 425)
|
(19 098)
|
(16 159)
|
(20 681)
|
(16 780)
|
(17 734)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1 100
N/A
|
3 005
+173%
|
4 929
+64%
|
7 595
+54%
|
9 493
+25%
|
13 996
+47%
|
15 566
+11%
|
12 465
-20%
|
15 888
+27%
|
13 382
-16%
|
13 156
-2%
|
14 195
+8%
|
13 823
-3%
|
17 037
+23%
|
17 276
+1%
|
14 280
-17%
|
18 013
+26%
|
15 245
-15%
|
16 647
+9%
|
|
| Operating Income | ||||||||||||||||||||||||||
| Operating Expenses |
(63)
|
(49)
|
(46)
|
(85)
|
(105)
|
(178)
|
(876)
|
(1 982)
|
(3 396)
|
(5 556)
|
(6 620)
|
(9 156)
|
(9 511)
|
(7 314)
|
(9 152)
|
(7 410)
|
(7 259)
|
(7 072)
|
(7 305)
|
(9 247)
|
(9 424)
|
(7 874)
|
(10 270)
|
(8 838)
|
(9 523)
|
|
| Selling, General & Administrative |
(63)
|
(49)
|
(46)
|
(85)
|
(105)
|
(178)
|
(620)
|
(1 511)
|
(2 740)
|
(4 677)
|
(5 758)
|
(8 158)
|
(8 423)
|
(6 438)
|
(7 828)
|
(6 204)
|
(6 068)
|
(6 054)
|
(6 216)
|
(7 482)
|
(7 707)
|
(6 492)
|
(8 445)
|
(7 633)
|
(8 189)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(205)
|
(341)
|
(446)
|
(585)
|
(527)
|
(563)
|
(634)
|
(492)
|
(630)
|
(556)
|
(507)
|
(504)
|
(551)
|
(1 093)
|
(1 041)
|
(838)
|
(959)
|
(486)
|
(634)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
(51)
|
(130)
|
(210)
|
(294)
|
(335)
|
(435)
|
(454)
|
(384)
|
(494)
|
(449)
|
(484)
|
(515)
|
(538)
|
(673)
|
(677)
|
(543)
|
(669)
|
(522)
|
(504)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(200)
|
(200)
|
(200)
|
0
|
0
|
0
|
0
|
0
|
(197)
|
(197)
|
(197)
|
|
| Operating Income |
(63)
N/A
|
(49)
+23%
|
(46)
+5%
|
(85)
-83%
|
(105)
-23%
|
(178)
-70%
|
224
N/A
|
1 023
+357%
|
1 533
+50%
|
2 040
+33%
|
2 873
+41%
|
4 840
+68%
|
6 055
+25%
|
5 150
-15%
|
6 736
+31%
|
5 972
-11%
|
5 897
-1%
|
7 123
+21%
|
6 518
-8%
|
7 790
+20%
|
7 851
+1%
|
6 407
-18%
|
7 743
+21%
|
6 406
-17%
|
7 124
+11%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||
| Interest Income Expense |
71
|
96
|
89
|
79
|
65
|
44
|
2 421
|
2 352
|
2 354
|
2 056
|
(701)
|
(1 402)
|
(1 639)
|
(1 247)
|
(1 155)
|
384
|
(231)
|
41
|
54
|
(557)
|
299
|
407
|
465
|
275
|
370
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(200)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(197)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
12
|
12
|
12
|
(5)
|
6
|
(7)
|
(9)
|
(16)
|
0
|
1
|
1
|
0
|
(57)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
(4 985)
|
(4 923)
|
(4 905)
|
(4 891)
|
47
|
57
|
38
|
(48)
|
(71)
|
(137)
|
(134)
|
0
|
25
|
(56)
|
(68)
|
(196)
|
(220)
|
(261)
|
(57)
|
|
| Pre-Tax Income |
8
N/A
|
48
+492%
|
43
-10%
|
(6)
N/A
|
(40)
-595%
|
(134)
-235%
|
(2 340)
-1 648%
|
(1 547)
+34%
|
(1 019)
+34%
|
(796)
+22%
|
2 219
N/A
|
3 517
+58%
|
4 466
+27%
|
3 667
-18%
|
5 522
+51%
|
6 214
+13%
|
5 537
-11%
|
7 157
+29%
|
6 589
-8%
|
7 162
+9%
|
8 083
+13%
|
6 422
-21%
|
7 990
+24%
|
6 421
-20%
|
7 380
+15%
|
|
| Net Income | ||||||||||||||||||||||||||
| Tax Provision |
(2)
|
(10)
|
(9)
|
1
|
9
|
29
|
(43)
|
(27)
|
(94)
|
136
|
206
|
(206)
|
(37)
|
(394)
|
(742)
|
(776)
|
(1 021)
|
(1 196)
|
(1 093)
|
(1 343)
|
(1 558)
|
(1 084)
|
(1 399)
|
(1 031)
|
(1 123)
|
|
| Income from Continuing Operations |
6
|
37
|
34
|
(5)
|
(31)
|
(104)
|
(2 383)
|
(1 574)
|
(1 112)
|
(660)
|
2 426
|
3 311
|
4 429
|
3 272
|
4 780
|
5 438
|
4 516
|
5 961
|
5 496
|
5 819
|
6 524
|
5 339
|
6 591
|
5 390
|
6 257
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(110)
|
(2)
|
(56)
|
(58)
|
(4)
|
(173)
|
(66)
|
(66)
|
(211)
|
(215)
|
(464)
|
(447)
|
(213)
|
(80)
|
351
|
342
|
465
|
361
|
|
| Net Income (Common) |
6
N/A
|
37
+492%
|
34
-10%
|
(5)
N/A
|
(31)
-593%
|
(104)
-235%
|
(2 383)
-2 182%
|
(1 684)
+29%
|
(1 114)
+34%
|
(716)
+36%
|
2 368
N/A
|
3 307
+40%
|
4 256
+29%
|
3 206
-25%
|
4 713
+47%
|
5 227
+11%
|
4 301
-18%
|
5 497
+28%
|
5 049
-8%
|
5 605
+11%
|
6 445
+15%
|
5 690
-12%
|
6 933
+22%
|
5 855
-16%
|
6 617
+13%
|
|
| EPS (Diluted) |
1.69
N/A
|
10
+492%
|
9.01
-10%
|
-1.21
N/A
|
-8.38
-593%
|
-28.07
-235%
|
-77.28
-175%
|
-48.48
+37%
|
-30.55
+37%
|
-20.87
+32%
|
64.97
N/A
|
93.51
+44%
|
121.7
+30%
|
450.77
+270%
|
119.13
-74%
|
132.06
+11%
|
112.16
-15%
|
722.79
+544%
|
133.51
-82%
|
145.82
+9%
|
838.27
+475%
|
801.97
-4%
|
977.16
+22%
|
825.31
-16%
|
932.92
+13%
|
|
Switch to:
Switch to:
See Also
Discover More
